October 15, 2014
CAMBRIDGE, UK -– Optibrium™, a developer of software for drug discovery, today announced the release of version 6.0 of its StarDrop™ software platform. This major new release introduces Card View™, an intuitive and highly flexible environment to view and interact with compound data in the context of discovery projects. Card View provides a unique and [...]
Luminex Corporation Announces Retirement of Patrick Balthrop, President and CEO
October 15, 2014
AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX) today announced that Patrick J. Balthrop, Sr. has retired as President and CEO. The board of directors has named Nachum "Homi" Shamir as President and CEO. Mr. Balthrop has resigned as a director but will continue to serve the company and its shareholders as a consultant to the [...]
Prestigious Academic Facility at Northwestern University Acquires the SyncroPatch 384/768PE
October 15, 2014
Livingston, NJ, USA -- The SyncroPatch 384/768PE offers the highest throughput in automated patch clamping history. The SyncroPatch 384/768PE focuses on providing both high quality recordings together with broad experimental versatility, two important hallmarks that clearly convinced scientific researchers at the Northwestern University Feinberg School of Medicine, Chicago, IL. The SyncroPatch 384/768PE is an advanced [...]
Illumina Accelerator Announces Investment in Inaugural Startup Class
October 15, 2014
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced the selection of three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics, Inc., EpiBiome, Inc., and Xcell Biosciences Inc. The Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It is [...]
Horizon Discovery Group Signs Collaboration Agreement with Top Ten Pharma Company
October 15, 2014
Cambridge, UK -- Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Horizon CombinatoRx division has been contracted by a top ten pharma company to profile a lead oncology asset. Under the terms of the agreement, Horizon CombinatoRx [...]
October 15, 2014
MENLO PARK, Calif. -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, today announced the release of new chemistry and software designed to enhance the performance and output of the platform by 45%. The latest release increases read length and improves accuracy to further accelerate innovative genomic research [...]
Bioo Scientific Offers Complete Line of Sensitive ELISAs for Quinolone Residue Detection
October 15, 2014
Austin, TX-- With the launch of several new ELISAs, Bioo Scientific now offers the broadest range of kits for quinolone residue detection with the best cross reactivity commercially available. A broad range of flouroquinolone residues can be detected using the AuroFlow™ Fluoroquinolone Strip Test Kit for Meat, the AuroFlow™ Fluoroquinolone Strip Test Kit for Milk [...]
October 15, 2014
MILFORD, Mass.-- Waters Corporation (WAT:NYSE) today introduced new size exclusion chromatography (SEC) columns for the characterization of proteins. For use with Waters® Alliance® HPLC, Waters ACQUITY® UPLC® H-Class Systems and other HPLC/UHPLC instruments, the XBridge® Protein BEH SEC Columns deliver optimal throughput and resolution for size-based separations of protein-based biotherapeutics. The columns are immediately available [...]
EnPresso growth systems now available to research scientists through Sigma-Aldrich
October 14, 2014
Cambridge, UK -- BioSilta Ltd, a developer of advanced, reagent-based microbial growth systems, today announced the signing of a non-exclusive worldwide distribution agreement with Sigma-Aldrich®(Nasdaq: SIAL). Research scientists now have the option of ordering BioSilta’s EnPresso® growth systems for microbial cell cultures through global supplier Sigma-Aldrich. BioSilta’s lead product range, EnPresso B growth systems, offer [...]
Agilent Technologies to Close Nuclear Magnetic Resonance Business
October 14, 2014
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE:A) today announced it is exiting its Nuclear Magnetic Resonance business. Agilent entered the NMR business in 2010, with the acquisition of Varian. Since then, the business has not met growth and profitability objectives. “Today’s announcement represents a difficult decision necessary to drive improved profitability,” said Mike McMullen, [...]

